BRÈVE

sur Vida Lifescience

Vida Lifescience Unveils Game-changing Active-Liposomal Creatine Plus with GAA & R-ALA for Enhanced Sports Performance

Vida Lifescience has introduced a revolutionary sports performance supplement, Active-Liposomal Creatine Plus with GAA & R-ALA, in partnership with Aurora Nutrascience. This new formula, touted to increase creatine levels in muscles up to 8.5 times more than creatine monohydrate alone, integrates advanced liposomal technology for optimal nutrient absorption. Aurora Nutrascience, known for its pioneering work in liposomal nutrient encapsulation, ensures the product's enhanced efficacy through an exclusive proprietary process.

Phil Bolden, Co-President of Vida Lifescience, highlighted the technology's ability to significantly improve the bioavailability of nutrients, contributing to more effective physical performance and recovery. The product combines Creatine Monohydrate, R-Alpha Lipoic Acid (R-ALA), and Guanidinoacetic Acid (GAA), positioning itself as a groundbreaking addition to the sports supplementation market. The use of non-GMO ingredients, organic fruit flavoring, and natural sweeteners underscores the company's commitment to product quality and consumer health.

Vida Lifescience, as the exclusive US distributor, offers the product on their website and through select retailers. This launch not only marks a significant advancement in nutritional science but also reflects the collaborative efforts of Vida Lifescience and Aurora Nutrascience in setting new benchmarks for sports performance supplements.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Vida Lifescience